Skip to main content

Integrative Medicine

The past decade has witnessed a substantial increase in the use of complementary and integrative modalities for the management of overall health and wellness. Integrative Medicine is grounded in the definition of health, and is an approach that strives to use the best evidence-based practices, rigorously developed and scientifically informed by medical research of safety and efficacy, to enhance optimal health outcome of conventional care. It puts the patient at the center and addresses the full range of physical, emotional, social, spiritual, and environmental influences that affect a person’s health and well-being (1). Integrative Medicine has gained recognition and establishment as a sub-specialty fellowship approved by the American Board of Integrative Medicine  

The Integrative Medicine course is complementary to the on-going training curriculum offered by the NCI Center for Cancer Training, including the flagship course, Translational Research in Clinical Oncology (TRACO).   The Spring 2021 course will be virtual at and there is no registration fee for this course.  Registration for the “Psilocybin Research Speaker Series” can be found here.

This course is designed for NIH fellows who want to enhance and broaden their knowledge of evidence-based comprehensive integrative healthcare to improve the lives of patients, including those with cancer.  Topics will be presented with research evidence, followed by clinical scenarios.  Students will have opportunity to better understand the current state of the science of each subject, as well as be introduced to cutting-edge advances in medical research, including technological advances.

Location and Time

The Integrative Medicine course and ”Psilocybin Research Speaker Series” will occur from March 25-June 10, 2021. Certain time-sensitive and cutting edge lectures may be opened to the NIH staff as well as the public, to include those from academia and the private sector,  creating a unique platform for scientific discourse.  Speakers will represent experts (domestic and international) in the field from government, academia, and the community. 

Integrative Medicine Course Schedule - Spring 2021
Date Lecture Speaker
March 25        

NIH ODS and Dietary Supplement

Nurtigenomics and personalized nutrition

B. Sorkin

G. Riscuta 

April 8

Medical ethics

Opioids and pain

D. Wendler

B. Karp & D. Mohapatra             

April 22

Psilocybin at the end of life

Neuropsychopharmacology of psilocybin

C. Grob

R. Griffiths

May 6

FDA cannabis clinical research guide

C. Taylor


May 13

Annual IM and Women's Health webinar

T.Bao, J. Clayton, H. Langvin, J. Ligibel, W. Lu, W. McCaskill-Stevens, A. Magnuson, T. Sanft and IM staff

May 20

Ketamine and synapse formation

Fatigue and Ketamine Trial

C. Liston

L. Saligan

May 27

Science policy considerations and perspective

Patient perspective on psychedelic medicine

Psilocybin in cancer patients 

S. Belouin

E. Rex

M. Agrawal

June 4

Psychedelic microdosing

Psilocybin and group therapy 

Psychedelic medicine and ethics

B. Szigeti

B. Anderson & A. Danforth

P.S. Apperbaum & M. Marks

June 7

New insights into psilocybin

Antidepressant-like effects of psilocybin

B. Roth

C. Nichols

June 10

Psilocybin assisted psychotherapy 

Psilocybin Research Final QA and Discussion

S. Ross

TBD and NIH Staff

Additional Information

Contact Dr. Terry Moody at and Dr. Dan Xi at

Faculty and Organizing Committee

  • Ann Berger, M.D., Clinical Center, NIH
  • Terry Moody, Ph.D., NCI, NIH
  • David Shurtleff, Ph.D., NCCIH, NIH
  • Dan Xi, Ph.D., NCI, NIH
  • Farah Zia, M.D., NCI, NIH


  1. Integrative Medicine and the Health of the Public: A Summary of the February 2009 Summit. Washington (DC): National Academies Press (US); 2009.
  2. Xi D, Bao T, Chen Q, et al. State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report. J Natl Cancer Inst Monogr. 2017 Nov;2017(52):003. PMCID: PMC6061228

Related Training Opportunities

This course is part of an ongoing training curriculum for NCI clinical and postdoctoral fellows. Each fall CCT offers the Translational Research in Clinical Oncology (TRACO) course, hosted by Dr. Terry Moody.

NIH offers additional training opportunities.

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Integrative Medicine was originally published by the National Cancer Institute.”